Back to Search
Start Over
Activation of peroxisome proliferator-activated receptor-alpha by fenofibrate prevents myocardial dysfunction during endotoxemia in rats.
- Source :
-
Critical care medicine [Crit Care Med] 2007 Mar; Vol. 35 (3), pp. 856-63. - Publication Year :
- 2007
-
Abstract
- Objective: To investigate the effects of fenofibrate, an activator of peroxisome proliferator-activated receptor-alpha, on cardiac function in a rat endotoxemia model.<br />Design: Prospective, randomized, controlled study.<br />Setting: University research laboratory.<br />Subjects: Three-month-old male Wistar rats.<br />Interventions: Animals were fed with standard diet containing no drug or fenofibrate (0.2%) for 14 days. They were then injected intravenously with either 5 mg/kg lipopolysaccharide (LPS and fenofibrate + LPS groups) or saline (control and fenofibrate groups).<br />Measurements and Main Results: In the LPS group, body weight loss, metabolic acidosis, and thrombocytopenia confirmed presence of systemic endotoxemia. LPS administration resulted in an early peak in plasma tumor necrosis factor-alpha, decreased cardiac contractility (isolated and perfused heart), reduced myofilament Ca2+ sensitivity (Triton-skinned cardiac fibers), and increased left ventricular nitric oxide (NO) end-oxidation products (NO(x) and NO2), without evidence of myocardial oxidative stress (thiobarbituric acid-reactive substances and antioxidant enzyme activities). Fenofibrate pretreatment (fenofibrate + LPS group) did not alter signs of endotoxemia but prevented reductions in both cardiac contractility and myofilament Ca2+ sensitivity. The peak of plasma tumor necrosis factor-alpha was attenuated, whereas myocardial NO(x) and NO2 remained similar to the LPS group. Oxidative stress was suggested from moderate increase in cardiac thiobarbituric acid-reactive substances and reduced glutathione peroxidase activity.<br />Conclusion: Fenofibrate, an activator of peroxisome proliferator-activated receptor-alpha, may prevent endotoxemia-induced cardiac dysfunction and reduction in myofilament Ca2+ sensitivity. Our data also suggest a mediating role for early peak plasma tumor necrosis factor-alpha, but not for myocardial NO production or oxidative stress.
- Subjects :
- Actin Cytoskeleton drug effects
Actin Cytoskeleton physiology
Animals
Calcium metabolism
Endotoxins immunology
Lipopolysaccharides immunology
Male
Myocardial Contraction physiology
Nitric Oxide metabolism
Oxidative Stress physiology
Premedication
Rats
Rats, Wistar
Tumor Necrosis Factor-alpha metabolism
Fenofibrate pharmacology
Hypolipidemic Agents pharmacology
Myocardial Contraction drug effects
PPAR alpha drug effects
Ventricular Dysfunction, Left physiopathology
Subjects
Details
- Language :
- English
- ISSN :
- 0090-3493
- Volume :
- 35
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Critical care medicine
- Publication Type :
- Academic Journal
- Accession number :
- 17255874
- Full Text :
- https://doi.org/10.1097/01.CCM.0000256843.75446.A0